Novo Nordisk

Novo Nordisk is a top pharmaceutical/ healthcare company based in Bagsvaerd, Denmark

Novo Nordisk is a top pharmaceutical/ healthcare company based in Bagsvaerd, Denmark.Novo Nordisk was founded in 1989 through the merger of two small Danish companies Nordisk Insulinlaboratorium and Novo Terapeutisk Laboratorium founded in 1923 and 1925, respectively.

Novo Nordisk is known worldwide for its innovation and research in diabetes care and development, in which it has a leadership history for over 90 years.

Novo Nordisk is a top pharmaceutical/ healthcare company based in Bagsvaerd, Denmark.

Novo Nordisk was founded in 1989 through the merger of two small Danish companies Nordisk Insulinlaboratorium and Novo Terapeutisk Laboratorium founded in 1923 and 1925, respectively.

The company is known worldwide for its innovation and research in diabetes care and development, in which it has a leadership history for over 90 years.

The company has leading positions within five major therapy areas:

  • Diabetes- Novo Nordisk has been a leader in diabetes care since 1923 and continues to pioneer the development of novel treatments for this serious condition.
  • Haemophilia - Novo Nordisk has an industry-leading pipeline portfolio, addressing the many faces of haemophilia and with the potential to innovate the treatment options. 
  • Protein delivery devices - Novo Nordisk is a world leader in combining protein research with the development of new delivery systems. In 1985, Novo Nordisk introduced the world’s first insulin pen. Novo Nordisk has developed more than 20 injection systems including durable, pre-filled and cartridges
  • Inflammation – developing novel immunotherapies that will significantly improve the lives of people with autoimmune and chronic inflammatory diseases such as rheumatoid arthritis, lupus, inflammatory bowel disease, and psoriatic arthritis.

Novo Nordisk has an active licensing venture investment and acquisition group charged with analysing and managing all incoming opportunities. Novo Nordisk has a long history of partnering, building numerous collaborative partnerships

Novo Nordisk has announced over 58 partnering / licensing deals since 2005. Analysis of these partnering deals shows a strong emphasis on partnerships in diabetes, inflammation, followed by haemophilia

Report: Partnering Deals and Alliances with Novo Nordisk

Examples of recent partnering and licensing deals announced by Novo Nordisk can be viewed in Current Partnering's Partnering Agreements with Novo Nordisk 2005-2013 review article.

Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with Novo Nordisk

Available reports from Current Partnering

Report: Partnering Deals and Alliances with Novo Nordisk

Report: Partnering Deals and Alliances with Big Pharma

Available resources for deal coverage for Novo Nordisk

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Novo Nordisk company profile, recent partnering, M&A and financing news and articles

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Print Friendly, PDF & Email